Introduction

Chapter
First Online:

Abstract

The care of the Sjogren’s syndrome (SS) patient is often shared by many specialists due to the multi-system involvement of this disease. Each of these specialists reads different journals and rarely attends common educational meetings. Thus, each specialty has a slightly different view of the “elephant” in the room. The primary goal of this book is to bring together a series of experts in different disciplines to provide a common dialogue regarding diagnosis and therapy for SS. Each chapter is written in a manner that preserves the sophistication of their respective field but that employs terminology that will be clear to other specialtists.

Although the rheumatologist frequently becomes the central “quarterback” in the treatment of the SS patient, he/she must be familiar with the diagnostic procedures and therapeutic approaches of the other specialties to avoid medication interactions and coordination of care. An additional goal for this volume is to include contributors from around the world including Europe, the Middle East, South America, Australia, and Asia as well as the USA.

Keywords

Sjogren’s syndrome Keratoconjunctivitis sicca Ophthalmology Otolaryngology Oral medicine Gastroenterology Neurology Pathogenesis Europe China India Israel Internet 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren’s syndrome: a clinical, pathological and serological study of 62 cases. Medicine (Baltimore). 1956;44:187–231.Google Scholar
  2. 2.
    Morgan W, Castleman B. A clinicopathologic study of Mikulicz’s disease. Am J Pathol. 1953;29:471–503.PubMedGoogle Scholar
  3. 3.
    Mikulicz JH. Uber eine eigenartige symmetrische Erkrankung der Tranen- und Mundspeicheldrusen. In: Billroth GT, editor. Beitr. Chir. Fortschr. Stuttgart; 1892. pp. 610–30.Google Scholar
  4. 4.
    Sjögren HS. Zur kenntnis der keratoconjunctvitis sicca (Keratitis folliformis bei hypofunktion der tranendrusen). Acta Opthalmol (Copenh). 1933;2:1–151.Google Scholar
  5. 5.
    Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Aydintug AO, Jedryka-Goral A, de Ramon E, Fernandez-Nebro A. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients. Medicine. 1999;78:167.PubMedCrossRefGoogle Scholar
  6. 6.
    Vitali C. Criteria for the classification of Sjogren’s syndrome. Primer Rheum Dis. 1998;11:458 (appendix).Google Scholar
  7. 7.
    Manthorpe R. New criteria for diagnosing Sjogren’s syndrome: a step forward?–or. Scand J Rheumatol. 2001;Suppl:14–20; discussion-2.Google Scholar
  8. 8.
    Fox R. Classification criteria for Sjogren’s syndrome. Rheum Dis Clin North Am: Curr Controversies Rheumatol. 1994;20:391–407.Google Scholar
  9. 9.
    Homma M, Tojo T, Akizuki M, Yamagata H. Criteria for Sjögren’s syndrome in Japan. Scand J Rheumatol. 1986;Suppl 61:26.Google Scholar
  10. 10.
    Fox RI. Sjogren’s syndrome. Lancet. 2005;366:321–31.PubMedCrossRefGoogle Scholar
  11. 11.
    Vitali C. Classification criteria for Sjogren’s syndrome. Ann Rheum Dis. 2003;62:94–5; author reply 5.PubMedCrossRefGoogle Scholar
  12. 12.
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos H, Alexander E, Carson S, Daniels T, Fox P, Fox R, Kassan S. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, McDougal JS, Rothfield NF, Smeenk RJ, Takasaki Y, Wiik A, Wilson MR, Koziol JA. Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum. 1997;40:1601–11.PubMedCrossRefGoogle Scholar
  14. 14.
    Lightfoot R. Cost effective use of laboratory tests in rheumatology. Bull Rheum Dis. 1997;46:1–3.PubMedGoogle Scholar
  15. 15.
    Infirmary E, Stone J, Caruso P, Deshpande V. Case 24-2009: a 26-year-old woman with painful swelling of the neck. N Engl J Med. 2009;361:511–8.CrossRefGoogle Scholar
  16. 16.
    Tan EM, Smolen JS, McDougal JS, Butcher BT, Conn D, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, Rothfield NF, Smeenk R, Takasaki Y, van Venrooij WJ, Wiik A, Wilson M, Koziol JA. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum. 1999;42:455–64.PubMedCrossRefGoogle Scholar
  17. 17.
    Daniels T, Fox P. Salivary and oral components of Sjögren’s syndrome. Rheum Dis Clin North Am. 1992;18:571.PubMedGoogle Scholar
  18. 18.
    Daniels TE. Labial salivary gland biopsy in Sjögren’s syndrome. Arthritis Rheum. 1984;27:147–56.PubMedCrossRefGoogle Scholar
  19. 19.
    Daniels TE, Whitcher JP. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjogren’s syndrome. Arthritis Rheum. 1994;37:869–77.PubMedCrossRefGoogle Scholar
  20. 20.
    Morbini P, Manzo A, Caporali R, Epis O, Villa C, Tinelli C, Solcia E, Montecucco C. Multilevel examination of minor salivary gland biopsy for Sjogren’s syndrome significantly improves diagnostic performance of AECG classification criteria. Arthritis Res Ther. 2005;7:R343–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Radfar L, Kleiner DE, Fox PC, Pillemer SR. Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers. Arthritis Care Res. 2002;47:520–4.CrossRefGoogle Scholar
  22. 22.
    Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren-Herlenius M, Jonsson R. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren’s syndrome. Arthritis Rheum. 2003;48:3187–201.PubMedCrossRefGoogle Scholar
  23. 23.
    Brennan MT, Sankar V, Leakan RA, Kleiner D, Atkinson JC, Wilkinson WE, Baum BJ, Pillemer SR. Risk factors for positive minor salivary gland biopsy findings in Sjogren’s syndrome and dry mouth patients. Arthritis Rheum. 2002;47:189–95.PubMedCrossRefGoogle Scholar
  24. 24.
    Yamada H, Nakagawa Y, Wakamatsu E, Sumida T, Yamachika S, Nomura Y, Mishima K, Saito I. Efficacy prediction of cevimeline in patients with Sjogren’s syndrome. Clin Rheumatol. 2007;26:1320–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Rheumatology Clinic, Scripps Memorial Hospital and Research FoundationLa JollaUSA

Personalised recommendations